{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T12:06:01Z","timestamp":1792325161344,"version":"4.4.0"},"reference-count":30,"publisher":"Massachusetts Medical Society","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100017117","name":"Denali Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017117","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1056\/nejmoa2508681","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T15:00:20Z","timestamp":1766761220000},"page":"39-50","source":"Crossref","is-referenced-by-count":23,"title":["An Intravenous Brain-Penetrant Enzyme Therapy for Mucopolysaccharidosis II"],"prefix":"10.1056","volume":"394","author":[{"given":"Joseph","family":"Muenzer","sequence":"first","affiliation":[{"name":"University of North Carolina School of Medicine, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara K.","family":"Burton","sequence":"additional","affiliation":[{"name":"Ann and Robert H. Lurie Children\u2019s Hospital of Chicago, Northwestern University, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Harmatz","sequence":"additional","affiliation":[{"name":"UCSF Benioff Children\u2019s Hospital, Oakland, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa S.","family":"Rajan","sequence":"additional","affiliation":[{"name":"UPMC Children\u2019s Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Jones","sequence":"additional","affiliation":[{"name":"Manchester University NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.P.","family":"van den Hout","sequence":"additional","affiliation":[{"name":"Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Montreal Children\u2019s Hospital, McGill University Health Centre, Montreal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil","family":"Bhalla","sequence":"additional","affiliation":[{"name":"Denali Therapeutics, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J.","family":"Engmann","sequence":"additional","affiliation":[{"name":"Denali Therapeutics, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imanol","family":"Zubizarreta","sequence":"additional","affiliation":[{"name":"Denali Therapeutics, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dong","sequence":"additional","affiliation":[{"name":"Denali Therapeutics, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Model","sequence":"additional","affiliation":[{"name":"Denali Therapeutics, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Watts","sequence":"additional","affiliation":[{"name":"Denali Therapeutics, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Troyer","sequence":"additional","affiliation":[{"name":"Denali Therapeutics, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Chin","sequence":"additional","affiliation":[{"name":"Denali Therapeutics, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Ho","sequence":"additional","affiliation":[{"name":"Denali Therapeutics, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","first-page":"103","article-title":"Levels of glycosaminoglycans in the cerebrospinal fluid of healthy young adults, surrogate-normal children, and Hunter syndrome patients with and without cognitive impairment.","volume":"5","author":"Hendriksz CJ","year":"2015","unstructured":"Hendriksz CJ, Muenzer J, Vanderver A, et al. Levels of glycosaminoglycans in the cerebrospinal fluid of healthy young adults, surrogate-normal children, and Hunter syndrome patients with and without cognitive impairment. Mol Genet Metab Rep 2015;5:103-106.28649553","journal-title":"Mol Genet Metab Rep"},{"key":"e_1_3_5_3_2","first-page":"101005","article-title":"Clinical characteristics and somatic burden of patients with mucopolysaccharidosis II with or without neurological involvement: an analysis from the Hunter Outcome Survey.","volume":"37","author":"Lau H","year":"2023","unstructured":"Lau H, Harmatz P, Botha J, Audi J, Link B. Clinical characteristics and somatic burden of patients with mucopolysaccharidosis II with or without neurological involvement: an analysis from the Hunter Outcome Survey. Mol Genet Metab Rep 2023;37:101005-101005.38053935","journal-title":"Mol Genet Metab Rep"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155188"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.09.039"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-009-1119-7"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-017-0075-x"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2023.107557"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0635-z"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-320106"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2025.109055"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e31817701e6"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-007-0635-4"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-014-9791-7"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S139601"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2024.108535"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay1163"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay1359"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.145445"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211057"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2024.108759"},{"key":"e_1_3_5_22_2","volume-title":"Vineland Adaptive Behavior Scales. 3rd ed","author":"Sparrow SS","year":"2016","unstructured":"Sparrow SS, Cicchetti DV, Saulnier CA. Vineland Adaptive Behavior Scales. 3rd ed. San Antonio, TX: Pearson Assessments, 2016."},{"key":"e_1_3_5_23_2","volume-title":"Vineland Adaptive Behavior Scales II: survey interview form. 2nd ed.","author":"Sparrow S","year":"2005","unstructured":"Sparrow S, Balla DA, Cicchetti DV. Vineland Adaptive Behavior Scales II: survey interview form. 2nd ed. Livonia, MN: Pearson Assessments, 2005."},{"key":"e_1_3_5_24_2","volume-title":"Bayley Scales of Infant and Toddler Development (Bayley-III). 3rd ed","author":"Bayley N","year":"2005","unstructured":"Bayley N. Bayley Scales of Infant and Toddler Development (Bayley-III). 3rd ed. San Antonio, TX: Harcourt Assessment, 2005."},{"key":"e_1_3_5_25_2","volume-title":"Kaufman assessment battery for children. Normative Update manual supplement. 2nd ed","author":"Kaufman AS","year":"2018","unstructured":"Kaufman AS, Kaufman NL, Drozdik L, Morrison J. Kaufman assessment battery for children. Normative Update manual supplement. 2nd ed. Indianapolis: Pearson Assessments, 2018."},{"key":"e_1_3_5_26_2","first-page":"303","article-title":"Recommendations for the primary analysis of continuous endpoints in longitudinal clinical trials.","volume":"42","author":"Mallinckrodt CH","year":"2008","unstructured":"Mallinckrodt CH, Lane PW, Schnell D, Peng Y, Mancuso JP. Recommendations for the primary analysis of continuous endpoints in longitudinal clinical trials. Ther Innov Regul Sci 2008;42:303-319 (https:\/\/link.springer.com\/article\/10.1177\/009286150804200402).","journal-title":"Ther Innov Regul Sci"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.12.1303"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365513.2023.2251003"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2003.08.004"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2011.02.018"},{"key":"e_1_3_5_31_2","first-page":"S100","article-title":"Management of infusion-related reactions to enzyme replacement therapy in a cohort of patients with mucopolysaccharidosis disorders.","volume":"47","author":"Miebach E","year":"2009","unstructured":"Miebach E. Management of infusion-related reactions to enzyme replacement therapy in a cohort of patients with mucopolysaccharidosis disorders. Int J Clin Pharmacol Ther 2009;47:Suppl 1:S100-S106.20040319","journal-title":"Int J Clin Pharmacol Ther"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2508681","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T17:00:26Z","timestamp":1767027626000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2508681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1056\/NEJMoa2508681"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2508681","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}